156 related articles for article (PubMed ID: 35615262)
1. Redirecting anti-Vaccinia virus T cell immunity for cancer treatment by AAV-mediated delivery of the VV B8R gene.
Cao D; Song Q; Li J; Chard Dunmall LS; Jiang Y; Qin B; Wang J; Guo H; Cheng Z; Wang Z; Lemoine NR; Lu S; Wang Y
Mol Ther Oncolytics; 2022 Jun; 25():264-275. PubMed ID: 35615262
[TBL] [Abstract][Full Text] [Related]
2. Enhanced antitumor efficacy of a novel oncolytic vaccinia virus encoding a fully monoclonal antibody against T-cell immunoglobulin and ITIM domain (TIGIT).
Zuo S; Wei M; He B; Chen A; Wang S; Kong L; Zhang Y; Meng G; Xu T; Wu J; Yang F; Zhang H; Wang S; Guo C; Wu J; Dong J; Wei J
EBioMedicine; 2021 Feb; 64():103240. PubMed ID: 33581644
[TBL] [Abstract][Full Text] [Related]
3. An engineered oncolytic vaccinia virus encoding a single-chain variable fragment against TIGIT induces effective antitumor immunity and synergizes with PD-1 or LAG-3 blockade.
Zuo S; Wei M; Xu T; Kong L; He B; Wang S; Wang S; Wu J; Dong J; Wei J
J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34949694
[TBL] [Abstract][Full Text] [Related]
4. A soluble chemokine-binding protein from vaccinia virus reduces virus virulence and the inflammatory response to infection.
Reading PC; Symons JA; Smith GL
J Immunol; 2003 Feb; 170(3):1435-42. PubMed ID: 12538705
[TBL] [Abstract][Full Text] [Related]
5. Vaccinia virus vectors with an inactivated gamma interferon receptor homolog gene (B8R) are attenuated In vivo without a concomitant reduction in immunogenicity.
Verardi PH; Jones LA; Aziz FH; Ahmad S; Yilma TD
J Virol; 2001 Jan; 75(1):11-8. PubMed ID: 11119568
[TBL] [Abstract][Full Text] [Related]
6. Immediate-early expression of a recombinant antigen by modified vaccinia virus ankara breaks the immunodominance of strong vector-specific B8R antigen in acute and memory CD8 T-cell responses.
Baur K; Brinkmann K; Schweneker M; Pätzold J; Meisinger-Henschel C; Hermann J; Steigerwald R; Chaplin P; Suter M; Hausmann J
J Virol; 2010 Sep; 84(17):8743-52. PubMed ID: 20538860
[TBL] [Abstract][Full Text] [Related]
7. Intra-tumoral delivery of CXCL11 via a vaccinia virus, but not by modified T cells, enhances the efficacy of adoptive T cell therapy and vaccines.
Moon EK; Wang LS; Bekdache K; Lynn RC; Lo A; Thorne SH; Albelda SM
Oncoimmunology; 2018; 7(3):e1395997. PubMed ID: 29399394
[TBL] [Abstract][Full Text] [Related]
8. Oncolytic vaccinia virus expressing a bispecific T-cell engager enhances immune responses in EpCAM positive solid tumors.
Wei M; Zuo S; Chen Z; Qian P; Zhang Y; Kong L; Gao H; Wei J; Dong J
Front Immunol; 2022; 13():1017574. PubMed ID: 36451817
[TBL] [Abstract][Full Text] [Related]
9. Nonreplicating recombinant vaccinia virus expressing CD40 ligand enhances APC capacity to stimulate specific CD4+ and CD8+ T cell responses.
Feder-Mengus C; Schultz-Thater E; Oertli D; Marti WR; Heberer M; Spagnoli GC; Zajac P
Hum Gene Ther; 2005 Mar; 16(3):348-60. PubMed ID: 15812230
[TBL] [Abstract][Full Text] [Related]
10. A study of the vaccinia virus interferon-gamma receptor and its contribution to virus virulence.
Symons JA; Tscharke DC; Price N; Smith GL
J Gen Virol; 2002 Aug; 83(Pt 8):1953-1964. PubMed ID: 12124459
[TBL] [Abstract][Full Text] [Related]
11. [The construction of attenuated Tiantan recombinant vaccinia virus vector with IFN-gamma receptor gene deletion].
Huang W; Liu Y; Duan DL; Li HS; Liu Y; Hong KX; Zhu JH; Shao YM
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Mar; 18(1):43-6. PubMed ID: 15340525
[TBL] [Abstract][Full Text] [Related]
12. Recombinant vaccinia virus-induced T-cell immunity: quantitation of the response to the virus vector and the foreign epitope.
Harrington LE; Most Rv Rv; Whitton JL; Ahmed R
J Virol; 2002 Apr; 76(7):3329-37. PubMed ID: 11884558
[TBL] [Abstract][Full Text] [Related]
13. Establishment of tumor-specific immunotherapy model utilizing vaccinia virus-reactive helper T cell activity.
Shimizu Y; Hasumi K; Masubuchi K; Okudaira Y
Eur J Immunol; 1988 Nov; 18(11):1773-8. PubMed ID: 2974424
[TBL] [Abstract][Full Text] [Related]
14. Vaccinia virus homologues of the Shope fibroma virus inverted terminal repeat proteins and a discontinuous ORF related to the tumor necrosis factor receptor family.
Howard ST; Chan YS; Smith GL
Virology; 1991 Feb; 180(2):633-47. PubMed ID: 1846491
[TBL] [Abstract][Full Text] [Related]
15. Vaccinia virus infection of mature dendritic cells results in activation of virus-specific naïve CD8+ T cells: a potential mechanism for direct presentation.
Yates NL; Alexander-Miller MA
Virology; 2007 Mar; 359(2):349-61. PubMed ID: 17056088
[TBL] [Abstract][Full Text] [Related]
16. Protection against vaccinia virus challenge by CD8 memory T cells resolved by molecular mimicry.
Cornberg M; Sheridan BS; Saccoccio FM; Brehm MA; Selin LK
J Virol; 2007 Jan; 81(2):934-44. PubMed ID: 17079318
[TBL] [Abstract][Full Text] [Related]
17. Attenuation of a vaccine strain of vaccinia virus via inactivation of interferon viroceptor.
Dénes B; Gridley DS; Fodor N; Takátsy Z; Timiryasova TM; Fodor I
J Gene Med; 2006 Jul; 8(7):814-23. PubMed ID: 16634110
[TBL] [Abstract][Full Text] [Related]
18. A systemically deliverable Vaccinia virus with increased capacity for intertumoral and intratumoral spread effectively treats pancreatic cancer.
Marelli G; Chard Dunmall LS; Yuan M; Di Gioia C; Miao J; Cheng Z; Zhang Z; Liu P; Ahmed J; Gangeswaran R; Lemoine N; Wang Y
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33500259
[TBL] [Abstract][Full Text] [Related]
19. Virus-encoded ectopic CD74 enhances poxvirus vaccine efficacy.
Walline CC; Deffit SN; Wang N; Guindon LM; Crotzer VL; Liu J; Hollister K; Eisenlohr LC; Brutkiewicz RR; Kaplan MH; Blum JS
Immunology; 2014 Apr; 141(4):531-9. PubMed ID: 24205828
[TBL] [Abstract][Full Text] [Related]
20. Qualitative differences in cellular immunogenicity elicited by hepatitis C virus T-Cell vaccines employing prime-boost regimens.
Tan WG; Zubkova I; Kachko A; Wells F; Adler H; Sutter G; Major ME
PLoS One; 2017; 12(7):e0181578. PubMed ID: 28732046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]